Ads
related to: epstein-barr virus
Search results
What Is Epstein-Barr Virus?
Health via Yahoo News· 1 year agoEpstein-Barr virus (EBV) is a common and highly contagious herpes virus that spreads through bodily fluids like saliva. About 90% of adults have had an...
Mark Cavendish reveals impact of Epstein-Barr virus and clinical depression in Netflix documentary
Cycling News via Yahoo News· 10 months agoTERNEUZEN NETHERLANDS APRIL 05 Mark Cavendish of The United Kingdom and Astana Qazaqstan Team prior...
What Is Mononucleosis (Mono)?
Health via Yahoo News· 1 year agoInfectious mononucleosis, or mono, is an infection caused by viruses—usually the Epstein-Barr virus (EBV). Mono can affect people of all ages, but it's...
Scientists Are Closer to Understanding How Epstein-Barr Infection Can Cause Multiple Sclerosis
Gizmodo via Yahoo News· 1 year agoNew research may provide clues to an enduring mystery about multiple sclerosis and the common germ...
Epstein-Barr may play a role in some long COVID; coronavirus can impair blood sugar processing by...
Reuters via Yahoo News· 2 years agoMore than 90% of adults have been infected with Epstein-Barr virus (EBV). Among 280 patients with...
New Documentary Details Mark Cavendish’s Fight With Depression and Epstein-Barr Virus
Bicycling via Yahoo News· 10 months agoNew Doc Details Mark Cavendish's Virus FightStuart Franklin - Getty Images After being diagnosed...
OPKO Health (OPK) to Develop EBV Vaccine With Latest Tie-Up
Zacks via Yahoo Finance· 1 year agoOPKO Health, Inc. OPK announced that its company, ModeX Therapeutics, Inc., has entered into an...
Atara’s cell therapy approach to MS falls short in study
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: Atara Biotherapeutics said late Wednesday that its experimental cell therapy for...
Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why
Zacks via Yahoo Finance· 6 months agoAtara Biotherapeutics ATRA is a biotech company focused on developing off-the-shelf cell therapies...
Merck, Opko Health sign deal for experimental Epstein-Barr virus vaccine
Reuters via Yahoo Finance· 1 year agoOpko Health Inc said on Wednesday it signed a deal with Merck & Co Inc potentially worth up to $922.5 million for its experimental Epstein-Barr virus vaccine. Merck will take over the clinical ...